King Khalid University Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2013
NCT04673500
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

King Khalid University | King Khalid University Hospital

Active Ingredients

Drugs in Phase 4 Trials (1)

Lactobacillus acidophilus (1 trial)

Drugs in Other Trials (4)

bupivacaine (Exparel) (1 trial)

lidocaine (xylocaine) (1 trial)

propofol (diprivan) (1 trial)

propolis (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Irritable Bowel Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 5